Muzykantov V R, Trubetskaya O V, Puchnina E A, Sakharov D V, Domogatsky S P
Institute of Experimental Cardiology, National Cardiology Research Center, Academy of Medical Sciences, Moscow, U.S.S.R.
Biochim Biophys Acta. 1990 Jun 12;1053(1):27-31. doi: 10.1016/0167-4889(90)90021-5.
The cytotoxic action of glucose oxidase conjugated with antibodies against the target cells has been examined in a culture of human endothelial cells. Internalizable (anti-endothelial, MoAb E25) and non-internalizable (anti-fibronectin, MoAb FN) monoclonal antibodies were employed as vectors. Anti-endothelial monoclonal antibody E78 (whether it can be internalized by endothelial cells is unclear) and polyclonal mouse antiserum to the human endothelium were also used. The conjugates were prepared by oxidation of the enzyme carbohydrate moiety with periodate. Free conjugates display similar enzyme activity in glucose solution. In contrast to glucose oxidase, conjugated with no-immune IgG, antibody-conjugated glucose oxidase binds specifically to target cells. The efficiency of targeting was different for various conjugates. Targeting via the anti-fibronectin antibody and anti-endothelial antiserum provided maximal quantitative binding of glucose oxidase to endothelial cells, while the conjugates with MoAb E25 and MoAb E78 monoclonal antibodies provided less effective binding. In the presence of glucose, targeted glucose oxidase generated H2O2. Hydrogen peroxide is relatively stable in buffer, but rapidly decays in the culture medium supplemented with 20% human serum. Though the quantitative binding of MoAb E25-conjugated glucose oxidase was minimal comparing to other conjugates, targeting via MoAb E25 produced the maximal cytotoxic effect as well as targeting via polyclonal antiserum. The killing efficiencies of MoAb FN-conjugated and MoAb E78-conjugated glucose oxidase were about 30-fold lower. The high efficiency of the MoAb E25-conjugated enzyme may be due to its internalization by target cells. Internalization can lead to unaccessibility of generated H2O2 for extracellular scavengers and pH optimization for glucose oxidase activity, which provides valuable advantages for the cytotoxicity of the conjugate. Thus, cytotoxicity of antibody-conjugated glucose oxidase depends not only on the efficiency of specific binding to the target cell, but also on the fate of cell-bound conjugate. Cytotoxicity is extremely effective in case of 'internalizable' conjugate and drastically less effective in case of 'non-internalizable' conjugate.
在人内皮细胞培养物中检测了与抗靶细胞抗体偶联的葡萄糖氧化酶的细胞毒性作用。可内化(抗内皮单克隆抗体E25)和不可内化(抗纤连蛋白单克隆抗体FN)的单克隆抗体被用作载体。还使用了抗内皮单克隆抗体E78(尚不清楚其是否能被内皮细胞内化)和抗人内皮多克隆小鼠抗血清。通过高碘酸盐氧化酶碳水化合物部分制备缀合物。游离缀合物在葡萄糖溶液中显示出相似的酶活性。与未免疫IgG偶联的葡萄糖氧化酶相比,抗体偶联的葡萄糖氧化酶能特异性结合靶细胞。不同缀合物的靶向效率不同。通过抗纤连蛋白抗体和抗内皮抗血清的靶向作用使葡萄糖氧化酶与内皮细胞实现了最大量的定量结合,而与单克隆抗体E25和单克隆抗体E78偶联的缀合物的结合效果较差。在有葡萄糖存在的情况下,靶向的葡萄糖氧化酶产生过氧化氢。过氧化氢在缓冲液中相对稳定,但在补充有20%人血清的培养基中会迅速分解。尽管与其他缀合物相比,单克隆抗体E25偶联的葡萄糖氧化酶的定量结合最少,但通过单克隆抗体E25的靶向作用产生的细胞毒性作用与通过多克隆抗血清的靶向作用一样大。单克隆抗体FN偶联和单克隆抗体E78偶联的葡萄糖氧化酶的杀伤效率约低30倍。单克隆抗体E25偶联酶的高效率可能是由于其被靶细胞内化。内化可导致所产生的过氧化氢无法被细胞外清除剂清除,并为葡萄糖氧化酶活性优化pH值,这为缀合物的细胞毒性提供了宝贵优势。因此,抗体偶联的葡萄糖氧化酶的细胞毒性不仅取决于与靶细胞特异性结合的效率,还取决于细胞结合缀合物的命运。对于“可内化”的缀合物,细胞毒性极其有效;对于“不可内化”的缀合物,细胞毒性则显著降低。